Literature DB >> 30079804

Agreement Between Parent Proxy Reports and Self-Reports of Adolescent Emotional Distress.

Chanhee Kim1, Heeseung Choi2, Heesung Ko2, Chang Gi Park1.   

Abstract

Parents' recognition of adolescents' emotional distress is a significant determinant of early detection and treatment of mental disorders. However, there is dearth of research exploring parent-adolescent agreement regarding adolescents' emotional distress. This cross-sectional, school-based study compared parents' proxy reports and self-reports of adolescent's emotional distress among 289 parent-adolescent dyads in Korea. Findings revealed low agreement between adolescents' and parents' reports of depression, anxiety, and anger, with an average polychoric r of .25 to .27. The agreement was particularly low for high school students, boys, and father-adolescent dyads. Additionally, parents tended to underestimate adolescents' emotional distress symptoms; a significant percentage of adolescents experiencing symptoms were rated in the normal range by parents, particularly high school students experiencing anger. Interventions are needed to help adolescents learn to manage and express their negative emotions. Moreover, parent education programs that improve parents' recognition of emotional distress and appropriate help-seeking behaviors are needed.

Entities:  

Keywords:  adolescent; emotional distress; informant agreement; parent proxy; school nursing

Year:  2018        PMID: 30079804     DOI: 10.1177/1059840518792073

Source DB:  PubMed          Journal:  J Sch Nurs        ISSN: 1059-8405            Impact factor:   2.835


  2 in total

1.  Caregiver-Child Discrepancies in Reports of Child Emotional Symptoms in Pediatric Chronic Pain.

Authors:  Sarah R Martin; Lonnie K Zeltzer; Laura C Seidman; Katherine E Allyn; Laura A Payne
Journal:  J Pediatr Psychol       Date:  2020-05-01

2.  Prevalence and associated factors of depression among Korean adolescents.

Authors:  Je-Yeon Yun; Halin Chung; Jin-Ah Sim; Young Ho Yun
Journal:  PLoS One       Date:  2019-10-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.